Klimadynon (Dry Extract From Cimicifuga Racemosa (L.) Nutt., Rhizoma (Black Cohosh) (5-10:1), Extraction Solvent)

The extract provides phytochemicals that can influence serotonergic pathways and interact with estrogen receptors. By modulating these neuroendocrine signals, the product may help stabilize temperature regulation, mood, and uterine smooth‑muscle activity, which are often disrupted during hormonal transitions.

The appropriate dose of Klimadynon is determined by the prescribing healthcare professional based on the individual’s condition, age, and overall health. Patients should follow the specific instructions provided by their clinician and not adjust the dose without medical advice.

Safety data for Klimadynon in pregnancy and lactation are limited. Current recommendations advise avoiding its use during pregnancy and while breastfeeding until more robust safety information becomes available. Women who are pregnant, planning pregnancy, or nursing should discuss alternatives with their healthcare provider.

To request Klimadynon, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Klimadynon’s active ingredient is a standardized black cohosh extract, which differs from phytoestrogen‑based supplements such as soy isoflavones. While both aim to alleviate menopausal symptoms, black cohosh is thought to act primarily through serotonergic modulation rather than direct estrogenic activity, offering an alternative mechanism for symptom relief.

Klimadynon should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight, and excessive heat to maintain its stability and potency over time.

Klimadynon is taken orally, typically as a capsule or tablet, depending on the specific commercial preparation. The exact administration schedule—such as frequency and timing—should be prescribed by a qualified healthcare professional and taken with water as directed.

Serious risks, though rare, include liver toxicity (elevated enzymes or hepatitis) and severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs of liver dysfunction, rash, swelling, or breathing difficulties while using the product.

Individuals with known hypersensitivity to black cohosh, those with active liver disease, pregnant or breastfeeding women, and patients taking estrogen‑containing therapies without medical supervision should avoid Klimadynon. Consultation with a healthcare provider is essential before starting the product.